Scholarly Index
Aditya Bagrodia
University of California San Diego; 8,478 total citations; 498 total publications; best world rank #5
University of California San Diego
8,478Total citations
498Total publications
50H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bladder and Urothelial Cancer Treatments | Lifetime | 489 | US 235 | 98.06 |
| Testicular diseases and treatments | Lifetime | 196 | US 86 | 97.69 |
| Urinary and Genital Oncology Studies | Lifetime | 324 | US 165 | 97.78 |
| Urological Disorders and Treatments | Lifetime | 696 | US 380 | 97.52 |
| Renal cell carcinoma treatment | Lifetime | 671 | US 351 | 97.36 |
| Pediatric Urology and Nephrology Studies | Lifetime | 853 | US 451 | 95.89 |
| Kidney Stones and Urolithiasis Treatments | Lifetime | 687 | US 264 | 94.48 |
| Minimally Invasive Surgical Techniques | Lifetime | 949 | US 337 | 85.33 |
| Testicular diseases and treatments | 2021-2025 | 5 | US 3 | 98.65 |
| Urologic and reproductive health conditions | 2021-2025 | 60 | US 13 | 95.24 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 285 | US 107 | 94.53 |
| Sexual Differentiation and Disorders | 2021-2025 | 117 | US 22 | 92.20 |
| Renal and related cancers | 2021-2025 | 332 | US 137 | 90.69 |
| Neuroblastoma Research and Treatments | 2021-2025 | 341 | US 132 | 90.97 |
| Renal cell carcinoma treatment | 2021-2025 | 580 | US 199 | 92.14 |
| Male Reproductive Health Studies | 2021-2025 | 318 | US 94 | 60.47 |